The Cannavist USA Issue 1 | Page 23

23 The number of qualifying conditions for Pennsylvania’s Medical Marijuana Program. This includes anxiety disorders, cancer, Crohn’s Disease, Epilepsy, HIV/ AIDS, Multiple Sclerosis (MS), opioid use disorder, Parkinson’s Disease and post-traumatic stress disorder (PTSD). 17,000 49% The number of patients on the Pennsylvania Medical Marijuana program Female respondents 2,079 42% Male respondents The number of patients who responded to the survey PTSD No.1 Reason 23.95% 36.53% of patients are accessing medical cannabis for chronic pain 45.79% of patients are utilizing oral products 41.46% of patients consume medical cannabis or CBD 2-5 times daily. 44.35% of patients are vaping 56% of patients do not have any negative medical cannabis effects 99.62% of patients say they experience: reduced pain, better sleep, less anxiety, less seizures, increased appetite, less vomiting/nausea, addiction withdrawal symptoms, decrease with muscle spasms, improved energy and less seizures. 23